Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Veracyte Inc のコンセンサス目標株価は $44.45 で、11 人のアナリストの評価に基づいています。最高値は $50(1 5, 2026 に Guggenheim が発表)、最安値は $37(12 5, 2024 に Goldman Sachs が発表)です。直近のアナリスト評価 3 件は Guggenheim、Morgan Stanley、Morgan Stanley により 1 5, 2026、12 2, 2025、11 11, 2025 に発表されました。Guggenheim、Morgan Stanley、Morgan Stanley の平均目標株価は $46 で、これらの最新評価から Veracyte Inc に対して 8.82% のupsideが示唆されています。
1アナリスト評価から算出
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 01/05/2026 | Buy Now | 18.29% | Guggenheim | $45 → $50 | Maintains | Buy | Get Alert |
| 12/02/2025 | Buy Now | 13.56% | Morgan Stanley | $40 → $48 | Maintains | Underweight | Get Alert |
| 11/11/2025 | Buy Now | -5.37% | Morgan Stanley | $28 → $40 | Maintains | Underweight | Get Alert |
| 11/05/2025 | Buy Now | 13.56% | UBS | $42 → $48 | Maintains | Buy | Get Alert |
| 11/05/2025 | Buy Now | 1.73% | Canaccord Genuity | $40 → $43 | Maintains | Hold | Get Alert |
| 11/05/2025 | Buy Now | 6.46% | Guggenheim | $40 → $45 | Maintains | Buy | Get Alert |
| 11/05/2025 | Buy Now | 4.09% | Needham | $41 → $44 | Maintains | Buy | Get Alert |
| 10/20/2025 | Buy Now | -5.37% | Canaccord Genuity | → $40 | Initiates | → Hold | Get Alert |
| 10/17/2025 | Buy Now | 6.46% | Freedom Capital Markets | → $45 | Initiates | → Buy | Get Alert |
| 05/08/2025 | Buy Now | -0.64% | UBS | $49 → $42 | Maintains | Buy | Get Alert |
| 05/08/2025 | Buy Now | -3% | Needham | $51 → $41 | Maintains | Buy | Get Alert |
| 04/09/2025 | Buy Now | -12.47% | Guggenheim | $45 → $37 | Maintains | Buy | Get Alert |
| 03/26/2025 | Buy Now | 6.46% | Stephens & Co. | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 03/20/2025 | Buy Now | 6.46% | Craig-Hallum | → $45 | Initiates | → Buy | Get Alert |
| 02/25/2025 | Buy Now | 15.92% | UBS | $46 → $49 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | 6.46% | Guggenheim | $45 → $45 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | Buy Now | 20.65% | Needham | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 01/29/2025 | Buy Now | 20.65% | Needham | $44 → $51 | Maintains | Buy | Get Alert |
| 12/05/2024 | Buy Now | -12.47% | Goldman Sachs | $38 → $37 | Downgrade | Buy → Neutral | Get Alert |
| 11/18/2024 | Buy Now | -33.76% | Morgan Stanley | $26 → $28 | Maintains | Underweight | Get Alert |
| 11/08/2024 | Buy Now | 4.09% | Scotiabank | $40 → $44 | Maintains | Sector Outperform | Get Alert |
| 11/07/2024 | Buy Now | -10.1% | Goldman Sachs | $34 → $38 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 8.82% | UBS | $43 → $46 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 4.09% | Needham | $37 → $44 | Maintains | Buy | Get Alert |
| 10/17/2024 | Buy Now | -5.37% | Leerink Partners | $35 → $40 | Maintains | Outperform | Get Alert |
| 10/16/2024 | Buy Now | 1.73% | UBS | → $43 | Initiates | → Buy | Get Alert |
| 10/10/2024 | Buy Now | -5.37% | Guggenheim | → $40 | Initiates | → Buy | Get Alert |
| 08/28/2024 | Buy Now | -12.47% | Needham | $31 → $37 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | -38.49% | Morgan Stanley | $21 → $26 | Maintains | Underweight | Get Alert |
| 08/07/2024 | Buy Now | -26.66% | Needham | $27 → $31 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | -36.12% | Needham | $33 → $27 | Maintains | Buy | Get Alert |
| 04/15/2024 | Buy Now | -33.76% | Goldman Sachs | $32 → $28 | Maintains | Buy | Get Alert |
| 02/26/2024 | Buy Now | -50.32% | Morgan Stanley | $22 → $21 | Maintains | Underweight | Get Alert |
| 02/23/2024 | Buy Now | -21.93% | Needham | $30 → $33 | Maintains | Buy | Get Alert |
| 11/10/2023 | Buy Now | -47.95% | Morgan Stanley | $23 → $22 | Maintains | Underweight | Get Alert |
| 11/08/2023 | Buy Now | -29.03% | Needham | $35 → $30 | Maintains | Buy | Get Alert |
| 10/23/2023 | Buy Now | -24.3% | Goldman Sachs | $37 → $32 | Maintains | Buy | Get Alert |
| 10/20/2023 | Buy Now | -24.3% | Goldman Sachs | $37 → $32 | Maintains | Buy | Get Alert |
| 10/10/2023 | Buy Now | -19.56% | Stephens & Co. | → $34 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2023 | Buy Now | -45.59% | Morgan Stanley | $22 → $23 | Maintains | Underweight | Get Alert |
| 08/09/2023 | Buy Now | -17.2% | Needham | $34 → $35 | Maintains | Buy | Get Alert |
| 05/08/2023 | Buy Now | -29.03% | Stephens & Co. | → $30 | Reiterates | → Overweight | Get Alert |
| 02/23/2023 | Buy Now | -19.56% | Needham | $33 → $34 | Maintains | Buy | Get Alert |
Veracyteの最新目標株価Veracyte。(NASDAQ:VCYT) の最新目標株価をGuggenheimが1 5, 2026日に発表した。このアナリスト会社はVeracyte ({{change}:{{mbol}}) {{{quoteName}}の{{change}:{{symbol}}からriseまで12ヶ月以内(18.29% upsideの可能性あり)と予想する$50.00の目標株価を設定しました。過去1年間に18のアナリスト会社がレーティングを報告しています。
Veracyteの最新のアナリストレーティングはVeracyteです。(NASDAQ:VCYT) の最新のアナリストレーティングはGuggenheimによるもので、VeracyteのVeracyteです。{actionCompany}}のbuy評価です。
Veracyteの最終アップグレードはありません。
Veracyte Incの最後の格下げは12 5, 2024日にGoldman SachsがVeracyte Incの目標株価を$38から$37に変更した時です。
アナリストは、公開財務諸表を調べたり、Veracyteの役員や顧客に話を聞いたり、決算の電話会議を傍聴したりと、広範な調査を行った上で株価の格付けを行っています。ほとんどのアナリストは3ヶ月ごとにこの作業を行いますので、毎年1社につき4つの格付けを得ることになります。companyName}}の最終レーティングは1 5, 2026日に提出されましたので、次のレーティングは1 5, 2027日あたりに提出されるものと思われます。
レーティングは主観的なものであり変化しますが、最新のVeracyte (VCYT) (VCYT) のレーティングは維持で、目標株価は$45.00から$50.00でした。現在の価格 Veracyte ({{exchange}}) (VCYT) の現在の取引価格は$42.27で、これはアナリストの予測レンジout ofです。
ブラウズ アナリスト評価と目標株価 全銘柄の
